Skip to main content

Jeong Man-pyo

Sungkyunkwan University · 医学

研究室紹介

Professor Jeong Man-pyo's research lab specializes in interstitial lung diseases, with a focus on the pathogenesis, diagnosis, and clinical outcomes of conditions such as pulmonary vasculitis, Sjögren’s syndrome-associated lung involvement, pulmonary fibrosis, and cryptogenic organizing pneumonia. The lab investigates the interplay between immune responses, genetic predispositions, and environmental triggers—particularly using animal models like repeated bleomycin exposure to study fibrotic lung disease. A key emphasis is placed on understanding the clinical and radiological features of these diseases, especially through high-resolution CT imaging and serological markers such as ANCA. The lab also explores the complex relationship between idiopathic pulmonary fibrosis and comorbid lung cancer, aiming to identify risk factors and improve patient outcomes.

interstitial lung diseasepulmonary fibrosisautoimmune vasculitisHRCT imaginglung cancer in IPF

Research Overview

Papers
443
Total Citations
9,215
Papers (5y)
52
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
52total
2020
2021
2022
2023
2025
Citations per year (5y)
497total
20202021202220232025

Selected Papers

15
1
Review|144 citations·2010
Imaging of Pulmonary Vasculitis
Man Pyo Chung, Chin A Yi, Ho Yun Lee, Joungho Han, Kyung Soo Lee
SJR Q1Radiology

The presence of pulmonary vasculitis can be suggested by a clinical presentation that includes diffuse pulmonary hemorrhage, acute glomerulonephritis, chronic refractory sinusitis or rhinorrhea, imaging findings of nodules or cavities, mononeuritis multiplex, multisystemic disease, and palpable purpura. Serologic tests, including the use of cytoplasmic antineutrophil cytoplasmic antibody (ANCA) and perinuclear ANCA, are performed for the differential diagnosis of the diseases. A positive cytopla

Pulmonary and Respiratory MedicineMedicine
2
Article|131 citations·2004
Amyloidosis and Lymphoproliferative Disease in Sj??gren Syndrome
Yeon Joo Jeong, Kyung Soo Lee, Man Pyo Chung, Joungho Han, Myung Jin Chung, Kun-Il Kim, Joon Beom Seo, Tomás Franquet
SJR Q3Journal of Computer Assisted Tomography

Sjogren syndrome accompanying pulmonary amyloidosis and lymphoproliferative disease manifests as multiple, large, thin-walled cysts; multiple nodules; parenchymal opacity; and bronchiectasis. These findings are caused by the interstitial or peribronchial infiltration of mixed amyloid and lymphoproliferative cells.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Article|127 citations·2003
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Man Pyo Chung, Martha M. Monick, Nabeel Hamzeh, Noah S. Butler, Linda S. Powers, Gary W. Hunninghake
SJR Q1American Journal of Respiratory Cell and Molecular Biology

Current hypotheses of the pathogenesis of many forms of pulmonary fibrosis suggest that (i) a stimulus results in repeated or prolonged episodes of lung injury, and (ii) genetic factors modulate the outcome of the injury. The commonly employed single-exposure bleomycin model results in only temporary fibrosis. Therefore, we evaluated whether repeated bleomycin exposures, in the setting of a genetic background more likely to develop a T helper 2 (Th2) response, would induce prolonged fibrosis. Lu

Pulmonary and Respiratory MedicineMedicine
4
Article|87 citations·2006
Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias
Yon Ju Ryu, Man Pyo Chung, Joungho Han, Tae Sung Kim, Kyung Soo Lee, Eun-Mi Chun, Sun Young Kyung, Sung Hwan Jeong, Thomas V. Colby, Hojoong Kim, O Jung Kwon
SJR Q1Respiratory MedicineOA
Pulmonary and Respiratory MedicineMedicine
5
Article|82 citations·2019
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study
Hongseok Yoo, Byeong‐Ho Jeong, Myung Jin Chung, Kyung Soo Lee, O Jung Kwon, Man Pyo Chung, Man Pyo Chung, Man Pyo Chung
SJR Q2BMC Pulmonary MedicineOA

BACKGROUND: Lung cancer is a common comorbidity of idiopathic pulmonary fibrosis (IPF) and has poor outcomes. The incidence and clinical factors related to development of lung cancer in idiopathic pulmonary fibrosis (IPF) are unclear. The aim of this study was to elucidate the cumulative incidence, risk factors, and clinical characteristics of lung cancer in IPF. METHODS: In this retrospective study, we analyzed clinical data for 938 patients who were diagnosed with IPF without lung cancer betwe

Pulmonary and Respiratory MedicineMedicine
6
Article|72 citations·2005
Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis
Kyeongman Jeon, Man Pyo Chung, Man Pyo Chung, Kyung Soo Lee, Myung Jin Chung, Myung Jin Chung, Joungho Han, Won‐Jung Koh, Gee Young Suh, Hojoong Kim, O Jung Kwon
SJR Q1Respiratory MedicineOA
Pulmonary and Respiratory MedicineMedicine
7
Article|36 citations·2020
Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
Man Pyo Chung, Moo Suk Park, In‐Jae Oh, Heung Bum Lee, Young Whan Kim, Jong Sun Park, Soo Taek Uh, Yun Seong Kim, Yangjin Jegal, Jin Woo Song
SJR Q1Advances in TherapyOA

ClinicalTrials.gov NCT03761082; the trial was retrospectively registered on December 3, 2018.

Pulmonary and Respiratory MedicineMedicine
8
Article|31 citations·2017
Serial chest CT in cryptogenic organizing pneumonia: Evolutional changes and prognostic determinants
Man Pyo Chung, Bo Da Nam, Kyung Soo Lee, Joungho Han, Jai S. Park, Jung Hwa Hwang, Min Jae, Tae Jung Kim
SJR Q1Respirology

BACKGROUND AND OBJECTIVE: Cryptogenic organizing pneumonia (COP) is corticosteroid responsive but residual computed tomography (CT) chest changes are often noted. The present study examined clinical and HRCT features of COP in which there was incomplete resolution. METHODS: We studied 93 patients with histopathologically confirmed COP and serial HRCT imaging. Clinical features were assessed, and serial CT images were analysed. Uni- and multivariate analyses were performed to determine clinical o

Pulmonary and Respiratory MedicineMedicine
9
Article|22 citations·2011
Interstitial Lung Disease
Man Pyo Chung
SJR Q2Tuberculosis & respiratory diseasesOA

Recently published articles on interstitial lung disease (ILD) have focused on the accurate diagnosis of idiopathic pulmonary fibrosis (IPF), serum biomarkers, acute exacerbation of IPF, the prognostic factors of ILD and the trial of new treatment.In particular, reports on the serum biomarkers such as CC-chemokine ligand 18, surfactant protein, circulating fibrocytes, and acute exacerbation of IPF are sufficient to be mentioned here.Pirfenidone therapy is the most important trial for the treatme

Pulmonary and Respiratory MedicineMedicine
10
Article|21 citations·2019
Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis
So Hyeon Bak, Hye Yun Park, Jin Hyun Nam, Ho Yun Lee, Jeong Hyun Lee, Insuk Sohn, Man Pyo Chung
SJR Q1PLoS ONEOA

Cluster analysis identified distinct phenotypes, which predicted prognosis of clinical outcome. Formula using quantitative CT values is useful to assess extent of pulmonary fibrosis and emphysema with normal lung function in patients with IPF.

Pulmonary and Respiratory MedicineMedicine
11
Article|8 citations·2011
Prognostic Significance of Different Subgroup Classifications of Critical Illness-Related Corticosteroid Insufficiency in Patients With Septic Shock
So Yeon Lim, Yong Soo Kwon, Maeng Real Park, Seo Goo Han, Kyeongman Jeon, Sang‐Won Um, Won‐Jung Koh, Man Pyo Chung, Hojoong Kim, O Jung Kwon, Gee Young Suh
SJR Q1Shock

The purpose of this study was to evaluate the prognostic significance of classification of patients with septic shock into different critical illness-related corticosteroid insufficiency subgroups. A retrospective observational study was conducted in patients with septic shock who underwent a short corticotropin stimulation test within 72 h of the onset of shock. Patients were classified into normal adrenal function (NOM), low basal cortisol (LBC) (basal cortisol, <10 μg/dL), or low Δ cortisol (

Endocrinology, Diabetes and MetabolismMedicine
12
Article|2 citations·1997
Pharmacokinetic Study of Isoniazid and Rifampicin in Healthy Korean Volunteers
Man Pyo Chung, Ho Cheol Kim, Gee Young Suh, Jeong Woong Park, Ho Joong Kim, Oh‐Jung Kwon, Chong H Rhee, Yong Choi Han, Hyojung Park, Myoung Min Kim, Kyung Eob Choi
SJR Q2Tuberculosis and Respiratory DiseasesOA

Background Isoniazid(INH) and rifampicin(RFP) are potent antituberculous drugs which have made tuberculous disease become decreasing. In Korea, prescribed doses of INH and RFP have been different from those recommended by American Thoracic Society. In fact they were determined by clinical experience rather than by scientific basis. Even there has been. few reports about pharmacokintic parameters of INH and RFP in healthy Koreans. Method Oral pharmacokinetics of INH were studied in 22 healthy nat

Infectious DiseasesMedicine
13
Article|2 citations·2006
Interstitial Lung Disease
Man Pyo Chung
SJR Q2Tuberculosis & respiratory diseasesOA
Pulmonary and Respiratory MedicineMedicine
14
Article|1 citations·2004
Methotrexate에 의한 약제 유발 과민성 폐렴 1례
정만표, 한정호, 이경수, 서현주, 박은하, 신성철, 전경만, 유창민, 편유장

Background:Methotrexate (MTX) has been used to treat a wide range of malignant and benign diseases including osteosarcoma, advanced stage non-Hodgkin’s lymphoma, psoriasis, severe rheumatoid arthritis, sarcoidosis, and Wegener’s granulomatosis. MTX-induced lung injury occurs in up to 10% of treated patients. Although both acute and chronic presentations have been described, typical manifestation of MTX-induced lung injury is subacute with symptoms usually developing within several months after s

15
Article|1 citations·2013
Connective Tissue Disease-Associated Interstitial Lung Disease
Man Pyo Chung
Korean Journal of MedicineOA

IntersInterstitial lung disease (ILD) is the most common pulmonary manifestation of connective tissue disease (CTD). It may develop in the patients with preexisting connective tissue diseases or may be the initial lone manifestation of an underlying CTD. Since ILD causes a potentially substantial morbidity and mortality in the patients with CTD, close collaboration among pulmonologists, rheumatologists, radiologists and pathologists is very essential to optimize the diagnostic evaluation and tre

Pathology and Forensic MedicineMedicine

Research Areas

Pulmonary and Respiratory MedicineEpidemiologyInfectious DiseasesSurgeryPhysiologyRheumatology

Jeong Man-pyoの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。